AP NEWS

2018 Pipeline Insight for Axial Spondyloarthritis - ResearchAndMarkets.com

September 14, 2018

DUBLIN--(BUSINESS WIRE)--Sep 14, 2018--The “Axial Spondyloarthritis - Pipeline Insight, 2018” drug pipelines has been added to ResearchAndMarkets.com’s offering.

This report offers a comprehensive insight of the pipeline (under development) therapeutics scenario and growth prospects across Axial Spondyloarthritis development.The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. ScopeThe report provides a snapshot of the pipeline development for Axial SpondyloarthritisThe report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for Axial SpondyloarthritisThe report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical informationProvides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Axial SpondyloarthritisThe report also covers the dormant and discontinued pipeline projects related to Axial SpondyloarthritisCompanies FeaturedKyowa Hakko Kirin Co.Janssen Research & DevelopmentEli Lilly and CompanyNovartis PharmaceuticalsAbbVieUCB Biopharma S.P.R.L.PfizerSun Pharma Global

Key Topics Covered

1. Report Introduction

2. Axial Spondyloarthritis Overview

3. Pipeline Therapeutics

An Overview of Pipeline Products for Axial Spondyloarthritis

4. Comparative Analysis

5. Products in Clinical Stage

5.1 Drug Name: Company Name

Product DescriptionResearch and DevelopmentProduct Development Activities

6. Products in Pre-Clinical and Discovery Stage

6.1 Drug Name: Company Name

Product DescriptionResearch and DevelopmentProduct Development Activities

7. Therapeutic Assessment

Assessment by Route of AdministrationAssessment by Stage and Route of AdministrationAssessment by Molecule TypeAssessment by Stage and Molecule Type

8. Inactive Products

8.1 Drug Name: Company Name

Product DescriptionResearch and DevelopmentProduct Development Activities

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/srz4cr/2018_pipeline?w=4.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180914005352/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Immune Disorders Drugs,Musculoskeletal Disorders Drugs

KEYWORD: EUROPE ASIA PACIFIC NORTH AMERICA SOUTH AMERICA AFRICA MIDDLE EAST

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY CLINICAL TRIALS PHARMACEUTICAL PROFESSIONAL SERVICES OTHER PROFESSIONAL SERVICES RESEARCH SCIENCE

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/14/2018 10:40 AM/DISC: 09/14/2018 10:40 AM

http://www.businesswire.com/news/home/20180914005352/en

AP RADIO
Update hourly